Cannabis Law Report

MAY 18, 2022

NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.

Safety 52

Safety Hemp Research and Development Data 52

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Systematic review and meta-analysis were performed to examine the efficacy and safety of MCs treatment among children.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

NORML

AUGUST 29, 2019

” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. ” For more information on the public health and safety of cannabis, please see NORML’s fact-sheets here.

Education 226

Education Data Retail Environment 226

Canna Law Blog

FEBRUARY 25, 2022

Exercise enforcement discretion review the safety data of a CBD dietary supplement consistent with the premarket safety review of a new dietary ingredient notification. Issue notice-and-comment rulemaking to establish that CBD is lawful under the FDCA.

CBD 84

CBD Data Safety Food 84

Cannabis Law Report

JANUARY 27, 2020

We take a look at where CBD regulation might be going and whether we should be concerned about safety writes Rob Verkerk PhD, scientific and executive director, ANH-Intl. We take a look at where CBD regulation might be going and whether we should be concerned about safety. A new ‘problem’: safety. ? A new ‘problem’: safety.

Safety 59

Safety CBD Food Seed-To-Sale 59

Cannabis Law Report

JANUARY 12, 2022

This level of understanding can inform best practices, improve outcomes, and contribute to sensible policy-making both in Oregon and beyond. Through this collaboration, the NPA and Maya will offer both the education and the technology infrastructure needed to make this possible, ensuring accessibility and safety to all communities. “We

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Canna Law Blog

AUGUST 8, 2023

The request came down via the Energy and Commerce Committee on July 27, when it published a Request for Information ( RFI ) to “interested parties” on the topic. Mostly, though, it seems they’ve been “looking at data” and firing off occasional warning letters to especially bad actors (as recently as last month, and going back to 2015).

CBD 72

CBD Topical Food Cannabinoids 72

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption 109

Consumption Patients Research and Development Data 109

Cannabis Law Report

NOVEMBER 15, 2021

At-large board member Andrew Turnage, Executive Director at the Georgia Access to Medical Cannabis Commission. Public Health and Data Monitoring. Lab Testing and Product Safety. Impaired Driving and Traffic Safety. More information about CANNRA is available at: www.cann-ra.org. Social and Economic Equity.

Compliance 98

Compliance Compliance Programs Topical 98

Cannabis Chronicles

MAY 22, 2019

This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”. McDonell said research institutions are limited in their access to cannabis users by federal laws that could affect funding. The clinic serves native and non-native patients, according to the news release.

Medicine 140

Medicine Research and Development Data Collective 140

Cannabis Law Report

SEPTEMBER 1, 2021

WORCESTER —On the eve of Wednesday, September 1, the Cannabis Control Commission (Commission)’s fourth birthday, adult-use Marijuana Establishments in Massachusetts surpassed $2 billion in gross sales , according to information reported in the state’s mandatory seed-to-sale tracking system, the agency announced today.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Veriheal

MAY 30, 2023

Cancer Pain Relief With Cannabis: What the New Study Shows Utilizing data from the Quebec Cannabis Registry in Canada, researchers sought to examine the safety and effectiveness of cannabis in addressing cancer pain. Note: The content on this page is for informational purposes only and is not intended to be professional medical advice.

Medicine 98

Medicine Treatment Patients Data 98

Cannabis Law Report

JULY 22, 2022

As the only track-and-trace company to have successfully taken over a government contract from another vendor, Metrc will replace the State’s current partner and implement its robust track-and-trace platform to help facilitate the Rhode Island Medical Cannabis Program’s data collection and regulatory oversight. and now Rhode Island.

Data 52

Data Programs Access Compliance 52

Cannabis Law Report

SEPTEMBER 11, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

MARCH 19, 2020

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 64

Hemp CBD Safety Topical 64

SpeedWeed

JULY 25, 2021

At long last the Georgia Access to Medical Marijuana Commission chose six companies that will be allowed to grow, manufacture and sell medical marijuana oil capped at 5% THC. Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Your submission has been received!

Media 52

Media Data Dispensary Access 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

MARCH 7, 2020

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71

Hemp CBD Research and Development Safety 71

Cannabis Law Report

APRIL 5, 2022

Metrc will help facilitate Mississippi’s medical cannabis program’s data collection and regulatory oversight through its robust track-and-trace platform. State regulators can also conveniently access this same information, which will be essential in creating a safe and secure marketplace for both patients and providers. “We

Safety 52

Safety Patients Dispensary Compliance 52

Cannabis Law Report

AUGUST 16, 2022

Seamless data tracking helps operators optimize inventory control, accurately report sales data, and improve cultivation management. We are eager to work side-by-side with the Metrc team to establish a well-regulated supply chain to ensure the long-term safety and security of patients and providers.”. including Washington, D.C.,

Seed-To-Sale 52

Seed-To-Sale Supply Chain Data Patients 52

Cannabis Law Report

JULY 28, 2021

Translating complex policy ideas into talking points, emails, briefs, and other publicly accessible communications. Collaborating with County departments, community leaders and other agencies to obtain data, provide analysis and convey results that support the Supervisor’s policy agenda.

Policy 105

Policy Legislation Research and Development Data 105

Veriheal

AUGUST 31, 2022

Harocopos and his team explain that OPCs, also known as supervised/safe consumption sites, are considered to be “health care facilities that aim to improve individual and community health, increase public safety and reduce the consequences of drug use, including overdose deaths, public drug use and syringe litter.” The Research Letter.

Consumption 104

Consumption Data Treatment Collective 104

SpeedWeed

JULY 7, 2021

Some issue broad tiers, others provide no information, and still others issue their cultivation licenses based on plant count. Here’s how the 282 acres stacked up by license type: Figuring out cultivation size nationally is probably more art than science given the data gaps that exist. How Much Canopy was Licensed in California?

Cultivation 52

Cultivation Media Data Compliance 52

Cannabis Law Report

JUNE 20, 2022

The findings in this report point to policies and practices that promote and preserve public health and safety, while allowing legal businesses to compete.”. The presence of an adult-use store in a consumer’s ZIP code may incentivize them to access some of their cannabis from the regulated market over the illicit market.

Programs 52

Programs Policy Consumption Access 52

Cannabis Law Report

AUGUST 10, 2021

The approval, made through the European Commission Decision Reliance Procedure (ECDRP), is based on data from a positive Phase 3 safety and efficacy study evaluating 25 mg/kg/day of GW’s cannabidiol. The safety profile observed was consistent with findings from previous studies, with no new safety risks identified.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JUNE 15, 2021

Under the supervision of the Executive Director of the Georgia Access to Medical Cannabis Commission. The position provides daily oversight of complaints of product safety issues, non-compliance, and patient safety issues, qualified personnel registration, as well as application and renewal process for all licenses issued by the Commission.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Canna Law Blog

APRIL 13, 2019

These products have not been shown to be safe or effective, and deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”. Marketing, labeling and sales : How should consumers be informed about the risks associated with such products (e.g.,

CBD 93

CBD Safety Topical Food 93

SpeedWeed

MARCH 19, 2021

Those policy areas include public safety concerns, youth prevention, minority access to the industry, and national standards on product testing and pesticides. The group plans to compile data and research, and to release white papers on these policy issues that can be used to inform lawmakers.

Business 52

Business Legalization Policy Education 52

Veriheal

JUNE 30, 2023

The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

NOVEMBER 24, 2019

Building the bridge between brands and the marketplace through testing and the importance of good data. These events, amongst other drivers, have shown the obvious need to regulate product safety in CBD and THC products in a holistic and standardized way.

Business 95

Business Data Wellness and Beauty Safety 95

SpeedWeed

AUGUST 12, 2021

Orr further wrote that the company has been working with the FDA for 18 months and has provided more than enough information about their “cultivation, extraction, manufacturing, use and safety” of their proprietary FSHE. . 2020 ), which was published in the journal Toxicology Reports , among other corrections.

Extraction 52

Extraction Hemp Safety Data 52

Cannabis Law Report

SEPTEMBER 29, 2022

The Act came into force on October 17, 2018, with two key objectives: To protect the health and safety of Canadians. Prior to the Act’s implementation in 2018, that number sat at 9% according to Health Canada data. Progress towards providing adults with access to strictly regulated, lower-risk, legal cannabis products.

Legislation 59

Legislation Consumption Safety Access 59

MMJ Recs

MARCH 16, 2024

Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols. Changes in regulations can have ripple effects throughout the industry, impacting supply chains, investment strategies, and consumer access to medical cannabis products.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects.

Research and Development 108

Research and Development Data THC Clinical Trials 108

The Cannigma

FEBRUARY 2, 2021

Patients can also access CBD products without a prescription through local pharmacies. We also lack information about the extent to which the PD community is informed about medicinal cannabis and whether they have tried cannabis and, if so, with what result.”.

Patients 87

Patients Clinical Trials Research and Development Treatment 87